Streptocid

Quick links to important sections

Streptocid

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Streptocid

What is Streptocid? A Foundational Definition

Property Description
Active ingredient Sulfanilamide (INN)
Form Powder, tablets, liniment, ointment
Pharmacological class Sulfonamide antibiotic (Antimicrobial agent)
Common use Management of bacterial infections
Origin Synthetic

What is Streptocid and What Type of Drug Is It?

Streptocid is a medication whose core component is the active ingredient Sulfanilamide (INN: p-Aminobenzenesulfonamide), classifying it as a first-generation sulfonamide antibiotic. This agent is recognized as a foundational chemotherapeutic agent, historically marking a significant advance in treating susceptible bacterial infections. The drug entity functions as a synthetic antimicrobial agent, and its status as a classic drug relates to the efficacy of the sulfonamide structure in combating bacterial pathogens.

Is Streptocid Natural or Synthetic, and What are its Forms?

Streptocid is a synthetic compound and is supplied as a single-entity product, containing only Sulfanilamide as the active pharmaceutical ingredient. This medicine is available in various dosage forms tailored for different routes of administration. The most common forms include tablets for oral (systemic) use, and preparations such as powder, liniment, or ointment for topical (dermatological) application. Sulfanilamide is used in these various forms for managing localized and systemic bacterial threats.

How Does Streptocid Generally Help?

Streptocid generally helps by operating as a bacteriostatic agent, which is defined as a substance that inhibits the growth and reproduction of bacteria rather than immediately destroying them. Its beneficial effect is achieved through folic acid synthesis interference. This action involves the Sulfanilamide structure chemically mimicking the natural bacterial nutrient para-aminobenzoic acid (PABA), consequently preventing the bacterial population expansion and allowing the host's immune system to clear the remaining organisms.

What side effects are possible with Streptocid?

Possible side effects and safety information

The safety profile for Streptocid (Sulfanilamide) is defined by its classification as a sulfonamide antibiotic, with documented adverse effects grouped across several major physiological systems. The regulatory information emphasizes that the potential for systemic toxicity exists due to drug absorption, even when used topically.


Documented Adverse Reaction Categories

Classification Examples of Documented Effects
System-Organ Classes Effects on the Blood and Lymphatic System, Skin and Subcutaneous Tissue, Hepatobiliary System, and Renal and Urinary System are officially noted.
Local Reactions With topical application, local sensitivity reactions such as burning or irritation are generally considered common.

Serious Safety Considerations

The most clinically significant risks associated with the sulfonamide class, including Sulfanilamide, involve severe, rare reactions documented in regulatory sources. These serious adverse reactions include blood dyscrasias such as Agranulocytosis and Aplastic Anemia, and severe cutaneous adverse reactions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). The risk of Fulminant Hepatic Necrosis is also noted.

Population-Specific Constraints

The official labeling defines specific safety constraints for certain populations. The medication is generally not recommended during the third trimester of pregnancy or while breastfeeding due to the documented risk of kernicterus in the newborn. Additionally, individuals with a known hypersensitivity to Sulfanilamide or other sulfonamides have this condition listed as a restriction for use, and caution is noted for individuals with G6PD deficiency.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Streptocid (Sulfanilamide) overdose focuses on the risk of systemic toxicity associated with the sulfonamide class, which may occur following excessive exposure. Documented presentations include central nervous system effects such as headache and convulsions, along with gastrointestinal disturbances, and signs of renal damage like crystalluria. Population-specific notes require caution for patients with impaired renal or hepatic function due to an increased risk of severe adverse events.


Severe Manifestations and Emergency Action Mandates

The most severe potential outcomes are classified as potentially fatal and include life-threatening organ and blood dyscrasias. These severe manifestations, documented in regulatory labeling, include fulminant hepatic necrosis and serious blood disorders such as agranulocytosis and aplastic anemia. Severe dermatological reactions, including Stevens-Johnson syndrome, are also reported with systemic exposure.

Immediate medical attention is required for any suspected overdose or the onset of severe symptoms like trouble breathing, convulsions, or early signs of blood disorders (e.g., jaundice or fever). Regulators mandate that users contact Poison Control and discontinue the drug immediately upon the first sign of these serious reactions.

Management Profile

Treatment is symptomatic and supportive as no specific antidote is known for Sulfanilamide toxicity. Frequent laboratory monitoring, including complete blood counts and urinalyses, is required to detect severe toxic effects promptly. The regulatory documents define the overdose profile by listing severe outcomes that necessitate this prompt, expert intervention.

Therapeutic Uses of Streptocid

What Streptocid treats: Main Uses and Benefits

Streptocid (Sulfanilamide) is commonly used in situations involving certain distressing symptoms linked to infections, and may provide supportive relief across several therapeutic domains.

Its core therapeutic function is related to the management of infections caused by susceptible organisms. Its usage is relevant for easing symptom clusters that may become intense or disruptive, associated with conditions like localized skin infections, acute urinary tract discomfort, and certain acute systemic symptom presentations (e.g., fever and sore throat).

This medication is generally applied in contexts where short-term symptomatic assistance is needed, such as when redness, swelling, and purulence appear on the skin, or when painful and frequent urination interferes with daily functioning. By providing supportive relief, Streptocid helps improve day-to-day comfort during symptomatic periods.

"This therapeutic use is applied across domains where additional symptomatic support is needed, supporting general well-being during symptomatic phases."

Quick Fact
Relief for Symptoms related to inflammatory or irritative states

Eligibility and Restrictions for Use

Eligibility to use Streptocid, which contains the sulfonamide antibiotic Sulfanilamide, is strictly determined by regulatory rules defining absolute prohibitions and conditional use. Usage is primarily allowed for adult patients for approved indications; however, several groups are formally excluded.

Populations and Conditions that Prohibit Use (Contraindications)

Population/Condition Restriction Status Regulatory Basis
Hypersensitivity to Sulfanilamide or any sulfonamide drug Contraindicated General Sulfonamide Labeling
Infants under two months of age Contraindicated General Sulfonamide Monograph
Pregnant women near term (third trimester) Contraindicated FDA Labeling
Nursing Mothers (Lactation) Contraindicated FDA Labeling
Marked hepatic damage Contraindicated General Sulfonamide Monograph

Populations Requiring Caution or Conditional Use

Use of Streptocid requires caution in patients with pre-existing conditions that may increase systemic risk, even if the drug is applied topically. This includes individuals with documented impaired renal function or impaired hepatic function. Caution is also required for patients with G6PD deficiency, severe allergy, bronchial asthma, or porphyria as stated in official precautions. Safety and effectiveness are typically not established in all pediatric populations. Older adults may use adult dosing but require caution due to the higher likelihood of decreased kidney function.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products: Official Profile

The official regulatory documentation for Streptocid (Sulfanilamide), particularly the topical formulation, states that no specific drug interactions have been documented in the product’s prescribing information. This means no formal metabolic, transporter, or direct drug-drug interaction mechanisms are explicitly detailed by the regulatory authority for this product.

However, due to the potential for systemic absorption of the sulfonamide component, certain precautions related to the drug class apply, especially concerning pharmacodynamic risks.

Interaction-Related Note Basis in Official Documentation
Pharmacodynamic Risk Co-administration with agents known to increase the risk of methemoglobinemia (e.g., certain local anesthetics) may lead to an increased adverse effect risk, contingent on systemic exposure.
Neuromuscular Agents Sulfanilamide may potentiate the neuromuscular blocking activities of agents like Cisatracurium, based on class-effect data.
Contraindicated Combinations No combination of medicines is explicitly prohibited due to interaction risk in the official label.
Timing Requirements No mandatory spacing or timing separation rules for co-administered products are specified.

Furthermore, the official label includes population-specific constraints driven by potential systemic exposure. Use is not recommended in nursing mothers due to the potential for absorbed sulfonamides to cause kernicterus in the newborn, and caution is advised during the third trimester of pregnancy.

Mechanism of Action

The core action of Sulfanilamide is its molecular role as a competitive inhibitor of the bacterial enzyme Dihydropteroate synthase (DHPS). This enzyme is essential for the pathogen to synthesize folic acid from its natural substrate, para-aminobenzoic acid (PABA). By binding to DHPS and preventing the PABA substrate from attaching, the molecule initiates a cascade that impairs the bacterial cell's growth capacity.

The primary cascade resulting from the DHPS blockade is a critical deficiency of tetrahydrofolate cofactors within the bacterial cell. This lack prevents the de novo construction of essential purine and thymidylate molecules, which are the required precursors for synthesizing DNA and RNA. This lack of precursors leads to the functional inability of the bacteria to divide or increase in number, resulting in bacteriostasis.

The mechanism's inhibitory action is constrained by its competitive nature and bacterial biology. A mechanism limitation arises if bacteria overproduce PABA or if they develop genetic changes that modify the DHPS enzyme, reducing its affinity for Sulfanilamide. In such scenarios, the drug’s inhibitory action is overridden, and the arrest of bacterial proliferation is prevented, allowing replication to continue.

Dosage and Administration Information

How Streptocid is Used: Official Administration Guidelines

The administration of Streptocid, which contains the active ingredient Sulfanilamide, is governed by the specific dosage form and its approved route. Administration instructions detail the required dose, frequency, and duration as established in professional guidelines.


Administration Scope

Feature Instruction
Route of Administration Primarily Intravaginal for the 15% cream formulation. It is also supplied for Topical (dermatological) application, with historical use of Oral forms for systemic needs.
Dosing and Frequency For the vaginal cream, the labeled dose is 1 applicatorful (approximately 6 g), applied once daily or twice daily (every 12 hours).
Special Procedural Conditions The full course of treatment must be maintained for 30 days, regardless of the timing of symptom improvement. For systemic use, maintaining adequate fluid intake is a required administration principle for the sulfonamide class.
Age-Group Administration Rules Use is not established as safe or effective in pediatric patients for the vaginal form. Systemic administration is not recommended in infants under 2 months of age due to class-specific absorption concerns.

Connection to the Overall Use Protocol

The official administration protocol mandates strict adherence to the route, dose, and frequency to ensure proper usage. For the 15% cream, this involves using the 1 applicatorful dose over the specified 30-day duration. These instructions define the precise operational framework and procedural conditions for using the medicine.

Recent Clinical Evidence

Research evidence / Overview of Studies for Streptocid

Evidence for Use in Localized Topical Applications

The research base for the use of Streptocid (Sulfanilamide) in localized applications, such as for skin infections or vulvovaginal conditions, is composed of early clinical trials and case series. Research has explored the product's use in patients dealing with conditions characterized by outcomes linked to inflammatory or irritative states. These studies focused on how symptoms, such as physical discomfort, discharge, or localized irritation, changed during the study period.

Findings describe patterns observed in the studies, where researchers evaluated changes in patient-reported outcomes over short-term periods, typically lasting only for the treatment duration (e.g., 7 to 14 days). The available evidence contributes to the broader evidence landscape but does not rely on contemporary, large-scale studies. The evidence quality varies across studies, and there is a notable absence of recent, large-scale, randomized, controlled trials (RCTs) that evaluate topical Streptocid using modern comparative methods.

Historical Evidence for Systemic Infections

Streptocid was historically studied for severe systemic infections, such as those caused by streptococci, and was evaluated in hospitalized adult and pediatric populations. The core evidence for this use comes from early clinical trials and case reports conducted in the 1930s. Research examined critical outcomes linked to systemic or functional imbalance, including measures of survival, mortality, and fever duration.

These historical studies report how symptoms evolved in the observed populations, with findings describing patterns observed in research contexts involving fluctuating or unstable symptoms. The research describes patterns where the active ingredient was observed in relation to certain acute changes monitored during the study periods.

Research Gaps and Uncertainties

The evidence landscape for Streptocid presents several significant limitations. The follow-up durations were limited across much of the evidence base, meaning long-term effects are not fully established, and durability is not well characterized. Additionally, modern data on its activity against current, resistant strains of bacteria are not readily available. The research highlights what is known about short-term changes in specific patient cohorts but provides limited insight into long-term effects or data for various special patient groups.

Key Studies & References Sulfanilamide | drug (Britannica - Overview of systemic and topical use history and efficacy)

Frequently Asked Questions (FAQ)

Common questions about Streptocid (FAQ)


Q: Does Streptocid come in a cream or just tablets?

A: Streptocid, which contains the active ingredient Sulfanilamide, is supplied in various forms. According to official product information, it is available as tablets for oral use, and as topical preparations like powder, liniment, or ointment. A 15% cream formulation is specifically approved for intravaginal use.


Q: What happens if you miss a dose of Streptocid?

A: Official patient information generally advises that if a dose is missed, it should be used as soon as it is remembered. However, if it is already close to the time for the next scheduled dose, the regulatory guidance states the missed dose is typically skipped, and the patient should proceed with the next scheduled dose. Instructions usually advise against using two doses at the same time.


Q: Is it normal to feel nauseous when taking Streptocid?

A: Yes, regulatory documents indicate that nausea, vomiting, and anorexia (loss of appetite) are listed as common gastrointestinal disturbances associated with the sulfonamide class of antibiotics, to which Streptocid belongs. Experiencing nausea is a recognized potential adverse effect of this medication class.


Q: Does Streptocid work against all kinds of bacteria?

A: Streptocid functions as a bacteriostatic agent by interfering with the synthesis of folic acid in bacteria. Because this mechanism only affects specific bacteria that rely on this process, it does not work against all types of bacteria. Its activity is limited only to organisms that are sensitive to the action of sulfonamides.


Q: Can the topical form of Streptocid cause a rash?

A: The possibility of allergic skin reactions, including a rash and pruritis (itching), is noted in association with sulfonamide treatment. While the most common local effects with topical use are localized burning or irritation, the potential for wider allergic skin reactions is noted in official regulatory labeling.


Q: Does using Streptocid repeatedly reduce its effectiveness?

A: The official information on the drug's mechanism indicates a biological limitation where bacteria may become less susceptible to its effects. This occurs if bacteria develop genetic changes, which is the biological basis for the development of bacterial resistance. Resistance can, in turn, reduce the drug's effectiveness over time.


Q: What should I do if my skin turns yellow while taking Streptocid?

A: The sulfonamide class of drugs is associated with a risk of serious effects on the liver, including Fulminant Hepatic Necrosis. The official safety documentation highlights that the sudden onset of yellow skin or eyes (jaundice) is a sign of potential liver-related toxicity. Patients are typically instructed to contact a healthcare provider if this occurs.


Q: Is it possible to be allergic to Streptocid but not other antibiotics?

A: Yes. Regulatory labeling states that Streptocid is contraindicated if a known hypersensitivity exists to Sulfanilamide or any other sulfonamide drug. This sensitivity is specific to the sulfonamide class and does not automatically indicate an allergy to non-sulfonamide antibiotics like penicillin.


Q: Is there any research about the long-term effects of using Streptocid?

A: Official regulatory reviews indicate that the follow-up periods in many of the available clinical studies are limited. This means that while short-term effects are known, the long-term effects are not fully established, and the durability of the treatment is not well characterized by modern data.


Q: What is the history of Streptocid's use in medicine?

A: Streptocid, or Sulfanilamide, is a first-generation sulfonamide antibiotic with a long history. Regulatory documents note that the core evidence for its systemic use comes from early clinical trials and case reports conducted in the 1930s, when it was studied for severe systemic infections.


Q: Can Streptocid cause stomach pain or indigestion?

A: As a member of the sulfonamide drug class, the official labeling for Streptocid notes the risk of gastrointestinal disturbances. These effects, which include nausea and vomiting, may also include associated symptoms like stomach pain or indigestion.


Q: What kind of research supports the use of Streptocid for wound healing?

A: Research has explored the product's use in localized applications for conditions linked to inflammatory or irritative states. However, regulatory summaries note the absence of recent, large-scale, randomized, controlled trials (RCTs) using modern comparative methods to evaluate this use.


Q: Is Streptocid effective against fungal infections?

A: No. Streptocid is classified as a sulfonamide antibiotic and a bacteriostatic agent. This means it is designed to inhibit the growth and reproduction of bacteria specifically, and it is not generally indicated for non-bacterial infections, such as those caused by fungi.


Q: What are the most common side effects people complain about with Streptocid?

A: For the topical application, common local effects generally include mild reactions like burning or irritation at the site of use. Systemically, as a sulfonamide, the most frequent adverse effects reported include gastrointestinal disturbances like nausea and vomiting.


Q: Can taking Streptocid make you sensitive to the sun?

A: Regulatory documents list effects on the Skin and Subcutaneous Tissue as a category of potential adverse reactions for sulfonamides. The sulfonamide drug class is associated with photosensitivity (increased sensitivity to the sun), and official caution regarding sun exposure is warranted.


Q: Does alcohol reduce the effectiveness of Streptocid?

A: The official product labeling for the topical formulation states that no specific drug interactions have been documented. However, regulatory sources do not explicitly address the interaction of alcohol with the drug's effectiveness. This is an important topic to address with a healthcare professional.


Q: Can I take ibuprofen or paracetamol while using Streptocid?

A: The official regulatory label focuses on interactions with agents that increase the risk of methemoglobinemia (a blood disorder) and certain neuromuscular blocking agents. There is no specific information documented in these sources regarding interactions with common over-the-counter pain relievers such as ibuprofen or paracetamol.


Q: Can Streptocid affect birth control pills?

A: Official regulatory documents caution against the use of Streptocid in pregnant or nursing women due to risks to the newborn. However, the official prescribing information for the topical product does not specifically address a documented interaction between Streptocid and oral contraceptive pills.


Q: Can Streptocid cause headaches or dizziness?

A: Official safety documents list effects on the nervous system as a category for other drugs in the sulfonamide class. While systemic toxicity is a risk, the specific symptoms of headache or dizziness are not explicitly detailed in the adverse reaction lists for this drug's regulatory profile.

How should Streptocid be stored and disposed of?

How to Store and Dispose of Streptocid (Sulfanilamide)

All storage and disposal procedures for Streptocid (Sulfanilamide) must comply strictly with official regulatory labeling to ensure product stability and safety.

Official Storage Conditions

The medication must be stored at room temperature, generally below 30°C (86°F), and should be placed in a dry area. It is mandatory to protect the product from light and freezing (Do not freeze). The product should be kept in the original container, which must be tightly closed.

Safety and Disposal

For child safety, the product must be stored out of the sight and reach of children at all times. Disposal of unused or expired Streptocid must be executed in accordance with all applicable local and national regulations. To protect the environment, the medicine must not be thrown into the household trash or flushed down a toilet or drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Streptocid found in:

A-Z Index: